Trial Profile
Efficacy and tolerability of flexible dose adjusted pregabalin as first-line add-on treatment of patients with focal seizures.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2011
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 27 Jul 2011 New trial record